|
1. Biologie
|
|
|
|
2.6 Etiologie - Environnement
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.2.3 Pharma - économie
|
|
|
Is Drug R&D Spending Going Up or Down? [In the Pipeline]
|
|
|
|
|
|
These
are not the results you’d expect if you asked people outside the
industry to predict them – in fact, you’d probably get some different
estimates from people inside the industry, particularly scientists who
have been through layoffs and re-organizations.
|
|
|
|
|
|
|
5.5.1.1 ASCO (général) - Industriels
|
|
|
|
6.1 Observation
|
|
|
|
6.10 Politiques
|
|
|
Canada Proposes to Amend Drug Pricing Regulations [RAPS]
|
|
|
|
|
|
The
move comes as the US government is undergoing a similar review of ways
to bring down the price of drugs in the US, though one major difference
between the neighbors is that Canada’s government has a means by which
it can control the price of medicines.
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
Robert Califf to join Google life sciences spinoff Verily [STAT]
|
|
|
|
|
|
“I’m
hoping to offer insights that will allow the company to better tailor
its technologies to meet the needs of doctors, other providers, health
systems and the patients they serve, and to drive evidence-based
approaches that will enable continuous learning and improvement.”
|
|
|
|
|
|